Rhumbline Advisers Becton Dickinson & CO Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Becton Dickinson & CO stock. As of the latest transaction made, Rhumbline Advisers holds 502,235 shares of BDX stock, worth $114 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

502,235

Previous 513,489 2.19%

Holding current value

$114 Million

Previous $120 Million 0.9%

% of portfolio

0.11%

Previous 0.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$221.47 - $242.41 $2.49 Million - $2.73 Million	-11,254 Reduced 2.19%	502,235 $121 Million
Q2 2024 Aug 01, 2024	SELL	$225.07 - $246.17 $1.12 Million - $1.22 Million	-4,962 Reduced 0.96%	513,489 $120 Million
Q1 2024 May 09, 2024	BUY	$233.45 - $247.73 $4.1 Million - $4.35 Million	17,561 Added 3.51%	518,451 $128 Million
Q4 2023 Feb 08, 2024	SELL	$232.24 - $267.23 $1.2 Million - $1.38 Million	-5,154 Reduced 1.02%	500,890 $122 Million
Q3 2023 Nov 09, 2023	BUY	$254.9 - $283.59 $130,508 - $145,198	512 Added 0.1%	506,044 $131 Million
Q2 2023 Aug 08, 2023	BUY	$238.39 - $265.32 $2.42 Million - $2.69 Million	10,151 Added 2.05%	505,532 $133 Million
Q1 2023 May 11, 2023	BUY	$229.71 - $259.35 $1.59 Million - $1.79 Million	6,912 Added 1.42%	495,381 $123 Million
Q4 2022 Feb 14, 2023	BUY	$218.29 - $256.91 $4.19 Million - $4.93 Million	19,192 Added 4.09%	488,469 $124 Million
Q3 2022 Nov 10, 2022	BUY	$51.03 - $264.23 $768,205 - $3.98 Million	15,054 Added 3.31%	469,277 $105 Million
Q2 2022 Aug 11, 2022	BUY	$234.74 - $275.42 $6.22 Million - $7.3 Million	26,495 Added 6.19%	454,223 $112 Million
Q1 2022 May 12, 2022	BUY	$243.64 - $270.48 $2.26 Million - $2.51 Million	9,279 Added 2.22%	427,728 $114 Million
Q4 2021 Feb 10, 2022	BUY	$230.08 - $250.94 $1.37 Million - $1.5 Million	5,969 Added 1.45%	418,449 $105 Million
Q3 2021 Nov 12, 2021	SELL	$232.72 - $256.47 $3.2 Million - $3.53 Million	-13,767 Reduced 3.23%	412,480 $101 Million
Q2 2021 Aug 05, 2021	SELL	$232.65 - $254.58 $4.88 Million - $5.34 Million	-20,967 Reduced 4.69%	426,247 $104 Million
Q1 2021 May 06, 2021	SELL	$232.09 - $256.88 $2.25 Million - $2.49 Million	-9,704 Reduced 2.12%	447,214 $109 Million
Q4 2020 Feb 10, 2021	BUY	$221.92 - $245.94 $520,624 - $576,975	2,346 Added 0.52%	456,918 $114 Million
Q3 2020 Nov 12, 2020	BUY	$215.77 - $276.76 $863,511 - $1.11 Million	4,002 Added 0.89%	454,572 $106 Million
Q2 2020 Aug 13, 2020	BUY	$219.9 - $263.41 $5.89 Million - $7.06 Million	26,790 Added 6.32%	450,570 $108 Million
Q1 2020 May 06, 2020	BUY	$195.69 - $279.01 $555,368 - $791,830	2,838 Added 0.67%	423,780 $97.4 Million
Q4 2019 Feb 05, 2020	BUY	$236.45 - $266.82 $538,633 - $607,815	2,278 Added 0.54%	420,942 $114 Million
Q3 2019 Oct 23, 2019	BUY	$230.58 - $256.08 $1.68 Million - $1.86 Million	7,274 Added 1.77%	418,664 $106 Million
Q2 2019 Aug 14, 2019	SELL	$217.4 - $246.08 $1.41 Million - $1.6 Million	-6,496 Reduced 1.55%	411,390 $104 Million
Q1 2019 May 01, 2019	SELL	$206.05 - $248.17 $2.05 Million - $2.47 Million	-9,954 Reduced 2.33%	417,886 $104 Million
Q4 2018 Jan 31, 2019	BUY	$204.73 - $257.93 $1.48 Million - $1.87 Million	7,238 Added 1.72%	427,840 $96.4 Million
Q3 2018 Nov 07, 2018	SELL	$233.07 - $256.0 $1.9 Million - $2.08 Million	-8,144 Reduced 1.9%	420,602 $110 Million
Q2 2018 Aug 06, 2018	BUY	$208.1 - $233.85 $2.08 Million - $2.34 Million	10,005 Added 2.39%	428,746 $103 Million
Q1 2018 May 02, 2018	SELL	$205.46 - $240.27 $5.06 Million - $5.92 Million	-24,648 Reduced 5.56%	418,741 $90.7 Million
Q4 2017 Feb 09, 2018	BUY	$189.0 - $222.64 $16.2 Million - $19.1 Million	85,616 Added 23.93%	443,389 $94.9 Million
Q3 2017 Nov 06, 2017	BUY	$186.89 - $198.9 $66.9 Million - $71.2 Million	357,773	357,773 $70.1 Million

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.7B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Becton Dickinson & CO Transaction History